Transplant-Related Data: Comparison Between G-CSF–Primed BM and G-CSF–Primed PB
| . | G-CSF–Primed BM . | G-CSF–Primed PB . | P . |
|---|---|---|---|
| Days to | |||
| PMN ≥ 0.5 × 109/L median (range) | 12 (10-14) | 11 (8-25) | .219 |
| PMN ≥ 1.0 × 109/L median (range) | 13 (10-16) | 11 (8-26) | .117 |
| PLT ≥ 20 × 109/L median (range) | 13 (10-23) | 11 (7-14) | .242 |
| PLT ≥ 50 × 109/L median (range) | 16 (10-30) | 14 (9-26) | .011 |
| Blood units transfused median (range) | 2 (0-6) | 2 (0-6) | .749 |
| PLT apheresis transfused median (range) | 3 (1-6) | 3 (2-7) | .205 |
| Posttransplant G-CSF doses median (range) | 10 (3-16) | 9 (6-11) | .151 |
| % of febrile patients | 70 | 50 | .320 |
| Days of fever/patient median (range) | 2.5 (1-6) | 3 (1-9) | .165 |
| Days of antibiotic median (range) | 7 (6-10) | 8 (3-17) | .746 |
| Days of hospitalization median (range) | 16.5 (13-22) | 15.5 (11-22) | .134 |
| . | G-CSF–Primed BM . | G-CSF–Primed PB . | P . |
|---|---|---|---|
| Days to | |||
| PMN ≥ 0.5 × 109/L median (range) | 12 (10-14) | 11 (8-25) | .219 |
| PMN ≥ 1.0 × 109/L median (range) | 13 (10-16) | 11 (8-26) | .117 |
| PLT ≥ 20 × 109/L median (range) | 13 (10-23) | 11 (7-14) | .242 |
| PLT ≥ 50 × 109/L median (range) | 16 (10-30) | 14 (9-26) | .011 |
| Blood units transfused median (range) | 2 (0-6) | 2 (0-6) | .749 |
| PLT apheresis transfused median (range) | 3 (1-6) | 3 (2-7) | .205 |
| Posttransplant G-CSF doses median (range) | 10 (3-16) | 9 (6-11) | .151 |
| % of febrile patients | 70 | 50 | .320 |
| Days of fever/patient median (range) | 2.5 (1-6) | 3 (1-9) | .165 |
| Days of antibiotic median (range) | 7 (6-10) | 8 (3-17) | .746 |
| Days of hospitalization median (range) | 16.5 (13-22) | 15.5 (11-22) | .134 |